Viewing StudyNCT00244686



Ignite Creation Date: 2024-05-05 @ 12:06 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00244686
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2020-11-25
First Post: 2005-10-25

Brief Title: This Record Contains Information About the Mepolizumab Compassionate Use CU Product Activities 104317 CU and Long-Term Access Study of Mepolizumab in HES 201956A Long-term Access Programme for Subjects With Severe Asthma 112562 Expanded Access for Patients With Hypereosinophilic
Sponsor: GlaxoSmithKline
Organization: GlaxoSmithKline

Conditions & Keywords Data

Conditions:
Name
Hypereosinophilic Syndrome
Keywords:
Name View
Mepolizumab View
Hypereosinophilic Syndrome View
Mepo View
HES View
Compassionate Use View